ai3Bio

ai3Bio develops treatments to transform the lives of patients with cancer.

Health and bio

ai3Bio raised $48M in a Series A round announced September 29, 2026, according to ai3.bio. Investors in that round: UPMC Enterprises, ZiffCap, Cockrell Interests, Tanis ventures.

Founders and team

• DV
  Dario Vignali Founder

  source: crunchbase.com
• GD
  Greg Delgoffe Founder

  source: crunchbase.com
• RF
  Robert Ferris Founder

  source: crunchbase.com
• FT
  Fabian Tenenbaum Board member

  source: crunchbase.com

Raise history

1. September 29, 2026
   Series A · $48M
   UUPMC Enterprises (lead), ZZiffCap (lead), CCockrell Interests, TTanis ventures
   Source: ai3.bio
2. January 28, 2026
   Website created

Investors

• CCockrell Interests
• TTanis ventures
• UUPMC Enterprises
• ZZiffCap

Related bio health companies

• TTriGemX Bio$94M · Oct 1, 2026
• SSedMed$4M · Oct 1, 2026
• SSharp$328K · Oct 1, 2026
• MM-BasedOct 1, 2026
• AAyna HealthOct 1, 2026
• BBiotia$9M · Oct 1, 2026
• RR1 Therapeutics$80.5M · Sep 30, 2026
• LLinux Laboratories$70M · Sep 30, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/ai3bio.